Attitude, Risk Perception and Public Acceptance against Coronavirus Disease 2019 Vaccination in Indonesia
DOI:
https://doi.org/10.3889/oamjms.2021.6635Keywords:
Coronavirus disease 2019, Vaccination, Attitude, Acceptance, Risk perceptionAbstract
BACKGROUND: The presence of a coronavirus disease 2019 (COVID-19) vaccine is very important to produce an immune response that slows down the pandemic.
AIM: This study aims to find out more about the perspective of the Indonesian people which is predicted to affect vaccine acceptance by the public.
METHODS: Quantitative research was conducted using an online survey via a Google form. The survey was conducted from January to February 2021.
RESULTS: There were 225 respondents. The attitude of the community towards the COVID-19 vaccination program, almost all respondents know the free vaccination program (94.4%) and know the purpose of the program (91.8%). There were 23% of respondents who felt that after being vaccinated they would be free from COVID-19 infection and 2.4% stated that they no longer needed to apply health protocols after being vaccinated. There were 8.2% who did not agree with the reasons they did not know its effectiveness, were worried about the side effects and were unsure about the safety of the COVID-19 vaccine.
CONCLUSION: In general, self-confidence, comfort, calculation of benefits versus disadvantages, and shared responsibility, influence a person’s decision to refuse or accept the vaccine.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Nadia S. Kebijakan Pelaksanaan Vaksinasi COVID-19. Direktorat Jenderal Pencegah dan Pengendali Penyakit Kementeri Kesehatan [Internet]. 2020;1-46. Available from: https://persi.or.id/wp-content/uploads/2021/01/paparan_adinkes_rakernassus.pdf.
Ministry of Health RI Director-General of P2P. Decree of the Director-General of Disease Prevention and Control Number Hk.02.02/4/1/2021 concerning Technical Guidelines for Vaccination Implementation in the Context of Combating the 2019 Corona Virus Disease (COVID-19) Pandemic. Indonesian Ministry of Health; 2020. p. 114. https://doi.org/10.24321/2455.7048.202013 DOI: https://doi.org/10.24321/2455.7048.202013
Ministry of Health of the Republic of Indonesia, ITAGI, WHO, UNICEF. Survey of COVID-19 Vaccine Acceptance in Indonesia, COVID-19 Handling Task Force. Indonesia: Ministry of Health of the Republic of Indonesia; 2020.
Callaghan T, Moghtaderi A, Lueck JA, Hotez P, Strych U, Dor A, et al. Correlates and disparities of intention to vaccinate against COVID-19. Soc Sci Med. 2021;272:113638. https://doi.org/10.1016/j.socscimed.2020.113638 PMid:33414032 DOI: https://doi.org/10.1016/j.socscimed.2020.113638
Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccines. 2020;38(45):7002-6. https://doi.org/10.1101/2020.04.23.20076513 PMid:32988688 DOI: https://doi.org/10.1016/j.vaccine.2020.09.041
Mendez-Ruiz MD, Alonso-Castillo MT, Alonso-Castillo MM, Uribe-Alvarado JI, Armendáriz-García NA. Relationship between risk perception and alcohol consumption in adolescents. SMAD Rev Eletrôn Saúde Ment Álcoole Drogas. 2015;11(3):161-7. https://doi.org/10.11606/issn.1806-6976.v11i3p161-167 DOI: https://doi.org/10.11606/issn.1806-6976.v11i3p161-167
Caserotti M, Girardi P, Rubaltelli E, Tasso A, Lotto L, Gavaruzzi T. Associations of COVID-19 risk perception with vaccine hesitancy over time for Italian residents. Soc Sci Med. 2021;272:113688. https://doi.org/10.1016/j.socscimed.2021.113688 PMid:33485215 DOI: https://doi.org/10.1016/j.socscimed.2021.113688
Sturm L, Kasting ML, Head KJ, Hartsock JA, Zimet GD. Influenza vaccination in the time of COVID-19: A national US survey of adults. Vaccine. 2021;39(14):1921-8. https://doi.org/10.1016/j.vaccine.2021.03.003 PMid:33715898 DOI: https://doi.org/10.1016/j.vaccine.2021.03.003
Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg Health Eur. 2021;1:100012. https://doi.org/10.1016/j.lanepe.2020.100012 PMid:33954296 DOI: https://doi.org/10.1016/j.lanepe.2020.100012
Ophinni Y, Hasibuan AS, Widhani A, Maria S, Koesnoe S, Yunihastuti E, et al. COVID-19 vaccines: Current status and implications for use in Indonesia. Acta Med Indonesia. 2020;52(4):388-412. PMid:33377885
World Health Organization. Evaluation of COVID-19 Vaccine Effectiveness. Geneva: World Health Organization; 2021. p. 70.
Akbar I. Covid-19 vaccination and state policy: Political economy perspective. J Acad Praja. 2021;4(1):244-54.
Echoru I, Ajambo PD, Bukenya EM. Acceptance and Risk Perception of COVID-19 Vaccine in Uganda: A Cross-Sectional Study in Western Uganda. Res Sq. 2020;2020:1-11. https://doi.org/10.21203/rs.3.rs-78780/v1 DOI: https://doi.org/10.21203/rs.3.rs-78780/v1
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Andi Susilawaty, Fajrin Noviyanto, Iis Afrianty, Armia Syahputra, Lia Kurniasari, Lukman Handoko, Respati Wulandari, Cipta Pramana (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0